Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

U Banerji, CML van Herpen, C Saura, F Thistiethwaite, S Lord, V Moreno, IR Macpherson, V Boni, C Rolfo, EGE de Vries, S Rottey, J Geenen, Ferry Eskens, M Gil-Martin, EC Mommers, NP Koper, P Aftimos

Research output: Contribution to journalArticleAcademicpeer-review

124 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1124-1135
Number of pages12
JournalLancet Oncology
Volume20
Issue number8
DOIs
Publication statusPublished - 2019

Cite this